ICR Q3 2026 SPAC Market Update and Outlook
NEW YORK – October 19, 2026 – ICR, a leading strategic communications and advisory firm, today released its Q3 2026...
Why Reputation is a Competitive Advantage in Private Markets
This article first appeared in O’Dwyer’s Public Relations Magazine and is reprinted by permission. Private markets have always been a...
Welcome to the Arena: Michael Buckley
For heritage brands, change can come with a cost. Stray too far from what consumers expect, and you risk diluting...
High-Growth in MedTech: Q3 Update
Modest improvement in performance fueled by multiple expansion; valuation premium for High-Growth MedTech expands in Q3 MedTech sector stock price...
Welcome to the Arena: Riad Sherif
Developing breakthrough medicines takes both courage and discipline. New treatments can transform patients’ lives, but the path to approval is...
SEC Proxy Rollback, ISS Probe & Tokenization
The October 2026 edition of The ICR D.C. Insider examines a busy month in Washington. The SEC has proposed returning...
Medical Device Companies Build Investor Credibility through Strategic Communications Well Before Commercial Launch
For a medical device startup, investor impressions form well in advance of marketing authorization. Beyond the communication of financing and...
Q3 2026 Equity Capital Markets Review
ICR Capital’s Equity Capital Markets and Equity-linked professionals review third-quarter 2026 activity, highlighting key market trends, issuance dynamics and the...
Welcome to the Arena: Maria Stipp
Today’s consumer has become much more discerning about what they put into their body. And when people go to buy...
Why Leadership Must Own the Story
This piece first appeared in the September 2026 issue of O’Dwyer’s PR Magazine. Two companies in the same sector report...
